Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 11

1.

BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension.

Machado RD, Pauciulo MW, Thomson JR, Lane KB, Morgan NV, Wheeler L, Phillips JA 3rd, Newman J, Williams D, Galiè N, Manes A, McNeil K, Yacoub M, Mikhail G, Rogers P, Corris P, Humbert M, Donnai D, Martensson G, Tranebjaerg L, Loyd JE, Trembath RC, Nichols WC.

Am J Hum Genet. 2001 Jan;68(1):92-102. Epub 2000 Dec 12.

2.
3.

Bone morphogenetic protein receptor-II mutation Arg491Trp causes malignant phenotype of familial primary pulmonary hypertension.

Zhicheng J, Lihe L, Zhiyan H, Xiansheng C, Yubao Z, Yuejin Y, Rutai H.

Biochem Biophys Res Commun. 2004 Mar 19;315(4):1033-8.

PMID:
14985116
4.

[Clinical and genetic characteristics of a Chinese family of primary pulmonary hypertension].

Jing ZC, Lu LH, Zou YB, You SJ, Han ZY, Zhang Q, Yang YJ, Hui RT, Cheng XS.

Zhonghua Yi Xue Za Zhi. 2004 Feb 2;84(3):199-202. Chinese.

PMID:
15059534
5.

Low frequency of BMPR2 mutations in a German cohort of patients with sporadic idiopathic pulmonary arterial hypertension.

Koehler R, Grünig E, Pauciulo MW, Hoeper MM, Olschewski H, Wilkens H, Halank M, Winkler J, Ewert R, Bremer H, Kreuscher S, Janssen B, Nichols WC.

J Med Genet. 2004 Dec;41(12):e127. No abstract available.

6.

Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.

Machado RD, Aldred MA, James V, Harrison RE, Patel B, Schwalbe EC, Gruenig E, Janssen B, Koehler R, Seeger W, Eickelberg O, Olschewski H, Elliott CG, Glissmeyer E, Carlquist J, Kim M, Torbicki A, Fijalkowska A, Szewczyk G, Parma J, Abramowicz MJ, Galie N, Morisaki H, Kyotani S, Nakanishi N, Morisaki T, Humbert M, Simonneau G, Sitbon O, Soubrier F, Coulet F, Morrell NW, Trembath RC.

Hum Mutat. 2006 Feb;27(2):121-32.

PMID:
16429395
7.

Evolutionary conservation and mutational spectrum of BMPR2 gene.

Wong WK, Morse JH, Knowles JA.

Gene. 2006 Mar 1;368:84-93. Epub 2005 Dec 20.

PMID:
16361068
8.

Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation.

Sztrymf B, Coulet F, Girerd B, Yaici A, Jais X, Sitbon O, Montani D, Souza R, Simonneau G, Soubrier F, Humbert M.

Am J Respir Crit Care Med. 2008 Jun 15;177(12):1377-83. doi: 10.1164/rccm.200712-1807OC. Epub 2008 Mar 20.

PMID:
18356561
9.

Clinical implications of determining BMPR2 mutation status in a large cohort of children and adults with pulmonary arterial hypertension.

Rosenzweig EB, Morse JH, Knowles JA, Chada KK, Khan AM, Roberts KE, McElroy JJ, Juskiw NK, Mallory NC, Rich S, Diamond B, Barst RJ.

J Heart Lung Transplant. 2008 Jun;27(6):668-74. doi: 10.1016/j.healun.2008.02.009. Epub 2008 Apr 9.

PMID:
18503968
10.

Identities and frequencies of BMPR2 mutations in Chinese patients with idiopathic pulmonary arterial hypertension.

Wang H, Cui QQ, Sun K, Song L, Zou YB, Wang XJ, Jia L, Liu X, Gao S, Zhang CN, Hui RT.

Clin Genet. 2010 Feb;77(2):189-92. doi: 10.1111/j.1399-0004.2009.01335.x. Epub 2009 Dec 10. No abstract available.

PMID:
20002458
11.

Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension.

Girerd B, Montani D, Eyries M, Yaici A, Sztrymf B, Coulet F, Sitbon O, Simonneau G, Soubrier F, Humbert M.

Respir Res. 2010 Jun 10;11:73. doi: 10.1186/1465-9921-11-73.

Supplemental Content

Support Center